Accuracy Coverage Pricing Contact
Becton, Dickinson And Co.

Becton, Dickinson And Co. (BDX)

Becton, Dickinson and Company (BD), incorporated in November 1906, is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. It provides customer solutions that are focused on managing medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; managing drug delivery; aiding anesthesiology care; managing the diagnosis of infectious diseases and cancers; advancing cellular research and applications, and supporting the management of diabetes. The Company caters to markets, such as healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company's subsidiaries include Accuri Cytometers, Inc., BD Norge AS, CareFusion Canada 307 ULC, Vital Signs Hong Kong Limited and Dantor S.A.

The Company's operations outside the United States include Europe; the Middle East and Africa (EMA); Greater Asia, which includes Japan and Asia Pacific; Latin America, which includes Mexico, Central America, the Caribbean and South America, and Canada. BD has manufacturing operations outside the United States in Bosnia and Herzegovina, Brazil, Canada, China, Dominican Republic, France, Germany, Hungary, India, Ireland, Italy, Japan, Mexico, the Netherlands, Singapore, Spain and the United Kingdom. It sells its products under various brands, such as BD Hypak, Alaris, Pyxis and Vacutainer, BD Kiestra, BD Max, BD BACTEC, SurePath, Veritor, BD ProbeTec and BD Viper.

BD Medical

The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems.

The diabetes care unit includes various products lines, such as syringes, pen needles and intravenous (IV) sets for the injection or infusion of insulin and other drugs used in the treatment of diabetes. The medication and procedural solutions unit includes various product lines, such as needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products, and surgical and laproscopic instrumentation. The medication management solutions unit includes intravenous medication safety and infusion therapy delivery systems, such as infusion pumps and dedicated disposables; medication compounding workflow systems, and automated medication dispensing and supply management systems. The pharmaceutical systems unit includes prefillable drug delivery systems provided to pharmaceutical companies and sold to end users as drug/device combinations. The businesses served by BD Medical are hospitals and clinics, physicians' office practices, consumers and retail pharmacies, governmental and nonprofit public health agencies, pharmaceutical companies, and healthcare workers.

BD Life Sciences

The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections (HAIs) and cancers. The BD Life Sciences segment produces research and clinical tools that facilitate the study of cells, the components of cells, and to gain an understanding of normal and disease processes. The BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences. The preanalytical systems unit includes integrated systems for specimen collection, and safety-engineered blood collection products and systems. The diagnostic systems unit includes automated blood culturing and tuberculosis culturing systems, molecular testing systems for infectious diseases and women's health, microorganism identification and drug susceptibility systems, liquid-based cytology systems for cervical cancer screening, rapid diagnostic assays, microbiology laboratory automation, and plated media. The biosciences unit includes fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, human immunodeficiency virus (HIV) and transplantation diagnostic/monitoring reagents and analyzers, and cell culture media supplements for biopharmaceutical manufacturing. The primary businesses served by BD Life Sciences are hospitals, laboratories and clinics; blood banks; healthcare workers; public health agencies; physicians' office practices; academic and government institutions, and pharmaceutical and biotechnology companies.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0c
2007 0.0c 0%
2008 0.0c 0%
2009 0.0c 0%
2010 0.0c 0%
2011 45.0c 100%
2012 189.0c 320.0%
2013 99.0c (47.6%)
2014 218.0c 120.2%
2015 240.0c 10.1%
2016 264.0c 10.0%
2017 292.0c 10.6%
2018 300.0c 2.7%
2019 Login required
2020 Login required
2021 Login required

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount
07 Mar 2012 30 Mar 2012 2011 Final Quarterly Paid 45c
06 Jun 2012 29 Jun 2012 2012 Interim Quarterly Paid 45c
05 Sep 2012 28 Sep 2012 2012 Interim Quarterly Paid 45c
06 Dec 2012 31 Dec 2012 2012 Interim Quarterly Paid 49.5c
06 Mar 2013 29 Mar 2013 2012 Final Quarterly Paid 49.5c
05 Jun 2013 28 Jun 2013 2013 Interim Quarterly Paid 49.5c
05 Sep 2013 30 Sep 2013 2013 Final Quarterly Paid 49.5c
06 Dec 2013 31 Dec 2013 2014 Interim Quarterly Paid 54.5c
06 Mar 2014 31 Mar 2014 2014 Interim Quarterly Paid 54.5c
05 Jun 2014 30 Jun 2014 2014 Interim Quarterly Paid 54.5c
05 Sep 2014 30 Sep 2014 2014 Final Quarterly Paid 54.5c
08 Dec 2014 31 Dec 2014 2015 Interim Quarterly Paid 60c
06 Mar 2015 31 Mar 2015 2015 Interim Quarterly Paid 60c
05 Jun 2015 30 Jun 2015 2015 Interim Quarterly Paid 60c
04 Sep 2015 30 Sep 2015 2015 Final Quarterly Paid 60c
08 Dec 2015 31 Dec 2015 2016 Interim Quarterly Paid 66c
08 Mar 2016 31 Mar 2016 2016 Interim Quarterly Paid 66c
07 Jun 2016 30 Jun 2016 2016 Interim Quarterly Paid 66c
07 Sep 2016 30 Sep 2016 2016 Final Quarterly Paid 66c
07 Dec 2016 30 Dec 2016 2017 Interim Quarterly Paid 73c
08 Mar 2017 31 Mar 2017 2017 Interim Quarterly Paid 73c
07 Jun 2017 30 Jun 2017 2017 Interim Quarterly Paid 73c
07 Sep 2017 29 Sep 2017 2017 Final Quarterly Paid 73c
07 Dec 2017 29 Dec 2017 2018 Interim Quarterly Paid 75c
08 Mar 2018 30 Mar 2018 2018 Interim Quarterly Paid 75c
07 Jun 2018 29 Jun 2018 2018 Interim Quarterly Paid 75c
06 Sep 2018 28 Sep 2018 2018 Final Quarterly Paid 75c
07 Dec 2018 31 Dec 2018 2019 Interim Quarterly Paid 77c
07 Mar 2019 29 Mar 2019 2019 Interim Quarterly Paid 77c
06 Jun 2019 28 Jun 2019 2019 Interim Quarterly Paid 77c
06 Sep 2019 30 Sep 2019 2019 Final Quarterly Paid 77c
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Interim Quarterly Forecast Login
Login Login 2020 Final Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Interim Quarterly Forecast Login
Login Login 2021 Final Quarterly Forecast Login

Becton, Dickinson And Co. optimized dividend - 12 month history

Optimized dividend graph demo

Becton, Dickinson And Co. share price - 12 month history

You're currently viewing outdated and/or artificial data.

Try the real thing now:

Activate Free Trial